{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:17:28Z","timestamp":1788484648528,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2021-2062, PIP 2022-0280, and PUE 2017-0035"],"award-info":[{"award-number":["PIP 2021-2062, PIP 2022-0280, and PUE 2017-0035"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2021-2062, PIP 2022-0280, and PUE 2017-0035"],"award-info":[{"award-number":["PIP 2021-2062, PIP 2022-0280, and PUE 2017-0035"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2021-2062, PIP 2022-0280, and PUE 2017-0035"],"award-info":[{"award-number":["PIP 2021-2062, PIP 2022-0280, and PUE 2017-0035"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PICT 2019-0942, and PICT-2021-CAT-II-00071"],"award-info":[{"award-number":["PICT 2019-0942, and PICT-2021-CAT-II-00071"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PICT 2019-0942, and PICT-2021-CAT-II-00071"],"award-info":[{"award-number":["PICT 2019-0942, and PICT-2021-CAT-II-00071"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PICT 2019-0942, and PICT-2021-CAT-II-00071"],"award-info":[{"award-number":["PICT 2019-0942, and PICT-2021-CAT-II-00071"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11064-024-04217-6","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T06:04:00Z","timestamp":1722492240000},"page":"2940-2956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neuroprotective Effects Exerted by a Combination of Selected Lactic Acid Bacteria in a Mouse Parkinsonism Model under Levodopa-Benserazide Treatment"],"prefix":"10.1007","volume":"49","author":[{"given":"Daiana","family":"P\u00e9rez Vis\u00f1uk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Guy","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"de Moreno de LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"4217_CR1","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28:203\u2013209","journal-title":"Ann Gastroenterol"},{"key":"4217_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","volume":"42","author":"N Dogra","year":"2022","unstructured":"Dogra N, Mani RJ, Katare DP (2022) The gut-brain Axis: two Ways Signaling in Parkinson\u2019s Disease. Cell Mol Neurobiol 42:315\u2013332","journal-title":"Cell Mol Neurobiol"},{"key":"4217_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.nrl.2019.03.017","volume":"37","author":"F Castillo-\u00c1lvarez","year":"2022","unstructured":"Castillo-\u00c1lvarez F, Marzo-Sola ME (2022) Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed) 37:492\u2013498","journal-title":"Neurologia (Engl Ed)"},{"key":"4217_CR4","first-page":"S1","volume":"75","author":"J Kulisevsky","year":"2022","unstructured":"Kulisevsky J (2022) Pharmacological management of Parkinson\u2019s disease motor symptoms: update and recommendations from an expert. Rev Neurol 75:S1\u2013S10","journal-title":"Rev Neurol"},{"key":"4217_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.25364","volume":"84","author":"AJ Espay","year":"2018","unstructured":"Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE (2018) Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts. Ann Neurol 84:797\u2013811","journal-title":"Ann Neurol"},{"key":"4217_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s40265-022-01747-7","volume":"82","author":"DG Di Luca","year":"2022","unstructured":"Di Luca DG, Reyes NGD, Fox SH (2022) Newly approved and Investigational Drugs for Motor Symptom Control in Parkinson\u2019s Disease. Drugs 82:1027\u20131053","journal-title":"Drugs"},{"key":"4217_CR7","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/advances\/nmab060","volume":"12","author":"JT Boelens Keun","year":"2021","unstructured":"Boelens Keun JT, Arnoldussen IA, Vriend C, van de Rest O (2021) Dietary approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson\u2019s Disease: a systematic review. Adv Nutr 12:2265\u20132287","journal-title":"Adv Nutr"},{"key":"4217_CR8","doi-asserted-by":"publisher","first-page":"729961","DOI":"10.3389\/fneur.2021.729961","volume":"12","author":"JF Baizabal-Carvallo","year":"2021","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M, Fekete R (2021) Intestinal decontamination therapy for Dyskinesia and Motor fluctuations in Parkinson\u2019s Disease. Front Neurol 12:729961","journal-title":"Front Neurol"},{"key":"4217_CR9","doi-asserted-by":"publisher","first-page":"574529","DOI":"10.3389\/fneur.2021.574529","volume":"12","author":"N Palacios","year":"2021","unstructured":"Palacios N, Hannoun A, Flahive J, Ward D, Goostrey K, Deb A, Smith KM (2021) Effect of levodopa initiation on the gut microbiota in Parkinson\u2019s Disease. Front Neurol 12:574529","journal-title":"Front Neurol"},{"key":"4217_CR10","doi-asserted-by":"publisher","first-page":"110995","DOI":"10.1016\/j.nut.2020.110995","volume":"79\u201380","author":"D Perez Vis\u00f1uk","year":"2020","unstructured":"Perez Vis\u00f1uk D, Savoy de Giori G, LeBlanc JG, de Moreno de LeBlanc A (2020) Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson\u2019s disease model. Nutrition 79\u201380:110995","journal-title":"Nutrition"},{"key":"4217_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-62703-251-3_17","volume":"964","author":"AR Carta","year":"2013","unstructured":"Carta AR, Carboni E, Spiga S (2013) The MPTP\/probenecid model of progressive Parkinson\u2019s disease. Methods Mol Biol 964:295\u2013308","journal-title":"Methods Mol Biol"},{"key":"4217_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40261-021-01038-1","volume":"41","author":"D Plantone","year":"2021","unstructured":"Plantone D, Pardini M, Rinaldi G (2021) Riboflavin in Neurological diseases: a narrative review. Clin Drug Investig 41:513\u2013527","journal-title":"Clin Drug Investig"},{"key":"4217_CR13","doi-asserted-by":"crossref","unstructured":"Perez Vis\u00f1uk D, Teran MDM, Savoy de Giori G, LeBlanc JG (2022) de Moreno de LeBlanc A Neuroprotective Effect of Riboflavin Producing Lactic Acid Bacteria in Parkinsonian Models. Neurochem Res 47:1269\u20131279","DOI":"10.1007\/s11064-021-03520-w"},{"key":"4217_CR14","doi-asserted-by":"publisher","first-page":"1254824","DOI":"10.3389\/fnagi.2023.1254824","volume":"15","author":"Y Quan","year":"2023","unstructured":"Quan Y, Xu J, Xu Q, Guo Z, Ou R, Shang H, Wei Q (2023) Association between the risk and severity of Parkinson\u2019s disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis. Front Aging Neurosci 15:1254824","journal-title":"Front Aging Neurosci"},{"key":"4217_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1468-1331.2009.02894.x","volume":"17","author":"V Belcastro","year":"2010","unstructured":"Belcastro V, Pierguidi L, Castrioto A, Menichetti C, Gorgone G, Ientile R, Pisani F, Rossi A, Calabresi P, Tambasco N (2010) Hyperhomocysteinemia recurrence in levodopa-treated Parkinson\u2019s disease patients. Eur J Neurol 17:661\u2013665","journal-title":"Eur J Neurol"},{"key":"4217_CR16","doi-asserted-by":"crossref","unstructured":"Levit R, Savoy de Giori G, de Moreno de LeBlanc A, LeBlanc JG (2019) Beneficial effect of a mixture of vitamin-producing and immune-modulating lactic acid bacteria as adjuvant for therapy in a recurrent mouse colitis model. Appl Microbiol Biotechnol","DOI":"10.1007\/s00253-019-10133-5"},{"key":"4217_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.foodres.2014.05.029","volume":"62","author":"M Juarez del Valle","year":"2014","unstructured":"Juarez del Valle M, Lai\u00f1o J, Savoy de Giori G, LeBlanc JGI (2014) Use of lactic acid Bacteria as a Biotechnological Strategy to increase Riboflavin levels in Soymilk. Food Res Int 62:1015\u20131019","journal-title":"Food Res Int"},{"key":"4217_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1139\/w2012-026","volume":"58","author":"JE Lai\u00f1o","year":"2012","unstructured":"Lai\u00f1o JE, Leblanc JG, Savoy de Giori G (2012) Production of natural folates by lactic acid bacteria starter cultures isolated from artisanal Argentinean yogurts. Can J Microbiol 58:581\u2013588","journal-title":"Can J Microbiol"},{"key":"4217_CR19","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/npp.2014.136","volume":"39","author":"K Szczesna","year":"2014","unstructured":"Szczesna K, de la Caridad O, Petazzi P, Soler M, Roa L, Saez MA, Fourcade S, Pujol A, Artuch-Iriberri R, Molero-Luis M, Vidal A, Huertas D, Esteller M (2014) Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor. Neuropsychopharmacology 39:2846\u20132856","journal-title":"Neuropsychopharmacology"},{"key":"4217_CR20","unstructured":"Paxinos G, Franklin K (2008) The mouse brain in stereotaxic coordinates. Academic"},{"key":"4217_CR21","unstructured":". Nutrients"},{"key":"4217_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nut.2018.03.056","volume":"54","author":"R Levit","year":"2018","unstructured":"Levit R, Savoy de Giori G, de Moreno de LeBlanc A, LeBlanc JG (2018) Protective effect of the riboflavin-overproducing strain Lactobacillus plantarum CRL2130 on intestinal mucositis in mice. Nutrition 54:165\u2013172","journal-title":"Nutrition"},{"key":"4217_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2007.03.025","volume":"418","author":"L Amazzal","year":"2007","unstructured":"Amazzal L, Lap\u00f4tre A, Quignon F, Bagrel D (2007) Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells. Neurosci Lett 418:159\u2013164","journal-title":"Neurosci Lett"},{"key":"4217_CR24","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1017\/S0007114521005031","volume":"128","author":"N Olfat","year":"2022","unstructured":"Olfat N, Ashoori M, Saedisomeolia A (2022) Riboflavin is an antioxidant: a review update. Br J Nutr 128:1887\u20131895","journal-title":"Br J Nutr"},{"key":"4217_CR25","doi-asserted-by":"publisher","first-page":"22028","DOI":"10.1038\/s41598-022-26463-w","volume":"12","author":"LW Wang","year":"2022","unstructured":"Wang LW, Lin HJ, Chao CM, Lin MT, Wang LY, Chein LH, Chang CP, Chio CC (2022) The interrelationships between neuronal viability, synaptic integrity, microglial responses, and amyloid-beta formation in an in vitro neurotrauma model. Sci Rep 12:22028","journal-title":"Sci Rep"},{"key":"4217_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/AEM.03296-13","volume":"80","author":"S del Carmen","year":"2014","unstructured":"del Carmen S, de Moreno de LeBlanc A, Martin R, Chain F, Langella P, Bermudez-Humaran LG, LeBlanc JG (2014) Genetically engineered immunomodulatory Streptococcus thermophilus strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities. Appl Environ Microbiol 80:869\u2013877","journal-title":"Appl Environ Microbiol"},{"key":"4217_CR27","doi-asserted-by":"crossref","unstructured":"Teixeira FG, Vila\u00e7a-Faria H, Domingues AV, Campos J, Salgado AJ (2020) Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson\u2019s Disease. Cells 9","DOI":"10.3390\/cells9020315"},{"key":"4217_CR28","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/jam.14918","volume":"130","author":"R Levit","year":"2021","unstructured":"Levit R, Savoy de Giori G, de Moreno de LeBlanc A, LeBlanc JG (2021) Evaluation of vitamin-producing and immunomodulatory lactic acid bacteria as a potential co-adjuvant for cancer therapy in a mouse model. J Appl Microbiol 130:2063\u20132074","journal-title":"J Appl Microbiol"},{"key":"4217_CR29","doi-asserted-by":"crossref","unstructured":"Pajares M, Manda AIR, Bosc\u00e1 G, Cuadrado L (2020) A Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells 9","DOI":"10.3390\/cells9071687"},{"key":"4217_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fncel.2018.00398","volume":"12","author":"I Garc\u00eda-Dom\u00ednguez","year":"2018","unstructured":"Garc\u00eda-Dom\u00ednguez I, Vesel\u00e1 K, Garc\u00eda-Revilla J, Carrillo-Jim\u00e9nez A, Roca-Ceballos MA, Santiago M, de Pablos RM, Venero JL (2018) Peripheral inflammation enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson\u2019s Disease. Front Cell Neurosci 12:398","journal-title":"Front Cell Neurosci"},{"key":"4217_CR31","doi-asserted-by":"crossref","unstructured":"Machado V, Z\u00f6ller T, Attaai A, Spittau B (2016) Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson\u2019s Disease-Lessons from Transgenic Mice. Int J Mol Sci 17","DOI":"10.3390\/ijms17020151"},{"key":"4217_CR32","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6:e28032","journal-title":"PLoS ONE"},{"key":"4217_CR33","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut microbiota regulate Motor deficits and neuroinflammation in a model of Parkinson\u2019s Disease. Cell 167:1469\u20131480 e1412","journal-title":"Cell"},{"key":"4217_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, R\u00fcb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 110:517\u2013536","journal-title":"J Neural Transm (Vienna)"},{"key":"4217_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY, Wu MS (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 16:129","journal-title":"J Neuroinflammation"},{"key":"4217_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.parkreldis.2018.11.014","volume":"59","author":"G Chapelet","year":"2019","unstructured":"Chapelet G, Leclair-Visonneau L, Clairembault T, Neunlist M, Derkinderen P (2019) Can the gut be the missing piece in uncovering PD pathogenesis? Parkinsonism Relat Disord 59:26\u201331","journal-title":"Parkinsonism Relat Disord"},{"key":"4217_CR37","doi-asserted-by":"publisher","first-page":"926702","DOI":"10.3389\/fmolb.2022.926702","volume":"9","author":"J Seira Curto","year":"2022","unstructured":"Seira Curto J, Surroca Lopez A, Casals Sanchez M, Tic I, Fernandez Gallegos MR, de Sanchez N (2022) Microbiome Impact on Amyloidogenesis. Front Mol Biosci 9:926702","journal-title":"Front Mol Biosci"},{"key":"4217_CR38","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2174\/1570159X21666221019115716","volume":"21","author":"K Xu","year":"2023","unstructured":"Xu K, Sheng S, Zhang F (2023) Relationship between gut Bacteria and Levodopa Metabolism. Curr Neuropharmacol 21:1536\u20131547","journal-title":"Curr Neuropharmacol"},{"key":"4217_CR39","doi-asserted-by":"publisher","first-page":"1046910","DOI":"10.3389\/fneur.2023.1046910","volume":"14","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Ye M, Yan F (2023) A review of studies on gut microbiota and levodopa metabolism. Front Neurol 14:1046910","journal-title":"Front Neurol"},{"key":"4217_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease. Ageing Res Rev 45:53\u201361","journal-title":"Ageing Res Rev"},{"key":"4217_CR41","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s10571-023-01319-7","volume":"43","author":"B Aktas","year":"2023","unstructured":"Aktas B (2023) Gut microbial alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent. Cell Mol Neurobiol 43:2815\u20132829","journal-title":"Cell Mol Neurobiol"},{"key":"4217_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A (2021) Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 7:27","journal-title":"NPJ Parkinsons Dis"},{"key":"4217_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnmol.2019.00171","volume":"12","author":"C Li","year":"2019","unstructured":"Li C, Cui L, Yang Y, Miao J, Zhao X, Zhang J, Cui G, Zhang Y (2019) Gut microbiota differs between Parkinson\u2019s Disease patients and healthy controls in Northeast China. Front Mol Neurosci 12:171","journal-title":"Front Mol Neurosci"},{"key":"4217_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S (2019) Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat Commun 10:310","journal-title":"Nat Commun"},{"key":"4217_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-023-00628-1","volume":"18","author":"Y Singh","year":"2023","unstructured":"Singh Y, Trautwein C, Romani J, Salker MS, Neckel PH, Fraccaroli I, Abeditashi M, Woerner N, Admard J, Dhariwal A, Dueholm MKD, Sch\u00e4fer KH, Lang F, Otzen DE, Lashuel HA, Riess O, Casadei N (2023) Overexpression of human alpha-synuclein leads to dysregulated microbiome\/metabolites with ageing in a rat model of Parkinson disease. Mol Neurodegener 18:44","journal-title":"Mol Neurodegener"},{"key":"4217_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40168-014-0050-9","volume":"2","author":"MG Langille","year":"2014","unstructured":"Langille MG, Meehan CJ, Koenig JE, Dhanani AS, Rose RA, Howlett SE, Beiko RG (2014) Microbial shifts in the aging mouse gut. Microbiome 2:50","journal-title":"Microbiome"},{"key":"4217_CR47","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.bbrc.2020.06.150","volume":"529","author":"W Li","year":"2020","unstructured":"Li W, Zhao Q, Wang J, Wang Y, Wen T (2020) Dcf1 deletion presents alterations in gut microbiota of mice similar to Parkinson\u2019s disease. Biochem Biophys Res Commun 529:1137\u20131144","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04217-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T13:16:40Z","timestamp":1725110200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04217-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["4217"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04217-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4378481\/v1","asserted-by":"object"}]},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}